About PPLadmin

This author has not yet filled in any details.
So far PPLadmin has created 11 blog entries.

Lilly Joins the Push for Non-Opioid Painkillers


In Pharma Lilly joins the push for non-opioid painkillers 03-Jun-2019 By Maggie Lynch Eli Lilly acquires exclusive worldwide rights for non-opioid treatment for chronic pain from Centrexion through a licensing agreement. HTTPS://WWW.IN-PHARMATECHNOLOGIST.COM/ARTICLE/2019/06/03/ELI-LILLY-LICENSES-NON-OPIOID-TREATMENT-FOR-47.5M 

Lilly Joins the Push for Non-Opioid Painkillers2020-12-10T19:32:22+00:00

Pain Medicine is Evolving – A Non-Addictive Opioid?


A non-addictive opioid under development by Phoenix PharmaLabs (Utah), PPL-103, has demonstrated the potential to be a treatment for opioid, as well as cocaine, addictions, as published in a poster by Lawrence Toll, PhD, professor of biomedical science at the Charles E. Schmidt College of Medicine at Florida Atlantic University, and chief neuropharmacologist of Phoenix [...]

Pain Medicine is Evolving – A Non-Addictive Opioid?2020-12-10T19:38:27+00:00

Phoenix Pharma Labs Technology Transfer Grant


  Phoenix PharmaLabs has received a Technology Transfer Grant from the National Institutes of Health to evaluate its lead compound as a potential treatment for cocaine addiction. Dr. Larry Toll, our CTO, was recruited earlier this year by Florida Atlantic University to become the University's first recruit under the 21st Century World Class Scholars [...]

Phoenix Pharma Labs Technology Transfer Grant2021-01-19T18:22:11+00:00
Go to Top